Actinium Pharmaceuticals, Inc. Share Price
Stocks
ATNM
US00507W2061
Biotechnology & Medical Research
|
Market Closed -
NYSE
01:30:00 10/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.230 USD | 0.00% |
|
+23.56% | -9.56% |
| 15/08 | Actinium Pharmaceuticals Expands Manufacturing Capacity for Actimab-A Program | CI |
| 15/08 | Actinium Pharmaceuticals, Inc. Amends Its Investigational New Drug | CI |
| Market Cap | 3.87Cr 3.33Cr 3.13Cr 2.86Cr 5.34Cr 368Cr 5.36Cr 37Cr 14Cr 187.48Cr 15Cr 14Cr 593.93Cr | P/E 2026 * |
8.79x | P/E 2027 * | -1.82x |
|---|---|---|---|---|---|
| Enterprise Value | 3.87Cr 3.33Cr 3.13Cr 2.86Cr 5.34Cr 368Cr 5.36Cr 37Cr 14Cr 187.48Cr 15Cr 14Cr 593.93Cr | EV / Sales 2026 * |
3.31x | EV / Sales 2027 * | - |
| Free-Float |
91.54% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ATNM | Delayed | |
Tradegate
| 7AY1 | Real-time | |
|
Börse Stuttgart
| 7AY1 | Delayed | |
|
CBOE
| ATNM | Real-time | |
|
Boerse Muenchen
| 7AY1 | Real-time | |
|
Deutsche Boerse AG
| 7AY1 | Delayed |
| 1 week | +23.56% | ||
| Current month | +20.59% | ||
| 1 month | +54.25% | ||
| 3 months | +16.04% | ||
| 6 months | +2.50% | ||
| Current year | -9.56% |
| 1 week | 1.01 |  | 1.3 |
| 1 month | 0.76 | | 1.3 |
| Current year | 0.74 | | 1.53 |
| 1 year | 0.74 | | 1.74 |
| 3 years | 0.74 | | 10.24 |
| 5 years | 0.74 | | 15.12 |
| 10 years | 0.74 | | 64.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sandesh Seth
CEO | Chief Executive Officer | 62 | 09/06/2017 |
Steffen Heeger
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2026 |
Adeela Kamal
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
C. Nicholson
BRD | Director/Board Member | 71 | 01/01/2008 |
Sandesh Seth
CHM | Chairman | 62 | 01/10/2013 |
| Director/Board Member | 68 | 08/11/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/09/26 | Free | Director | 1,57,000 | 0.5004% | ||
| 02/09/26 | Free | Chief Executive Officer | 29,11,274 | 9.2790% | ||
| 02/09/26 | Free | Director | 1,57,000 | 0.5004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +23.56% | -23.12% | -81.16% | 3.87Cr | |
| -0.94% | +0.31% | +40.04% | +103.25% | 6.92TCr | |
| -0.07% | -2.37% | +33.44% | +78.50% | 6.3TCr | |
| +3.13% | +6.00% | -12.19% | +390.48% | 2.73TCr | |
| -0.54% | -3.74% | -4.41% | -18.31% | 2.48TCr | |
| -0.93% | -1.29% | +25.30% | +16.70% | 2.58TCr | |
| -1.43% | -0.61% | +22.71% | -19.01% | 2.01TCr | |
| -4.27% | +2.67% | +219.02% | +362.48% | 1.85TCr | |
| -1.43% | -1.80% | -8.64% | +537.09% | 1.49TCr | |
| +1.14% | +2.53% | +54.76% | +163.82% | 1.43TCr | |
| Average | -0.53% | +2.08% | +34.69% | +153.38% | 2.78TCr | |
| Weighted average by Cap. | -0.48% | -0.76% | +36.87% | +141.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.17Cr 1Cr 94.53L 86.13L 1.61Cr 111.02Cr 1.62Cr 11Cr 4.33Cr 57Cr 4.38Cr 4.29Cr 179.17Cr | - |
| Net income | 49.06L 42.22L 39.75L 36.22L 67.77L 47Cr 68.04L 4.71Cr 1.82Cr 24Cr 1.84Cr 1.8Cr 75Cr | -3.17Cr -2.73Cr -2.57Cr -2.34Cr -4.38Cr -301.71Cr -4.4Cr -30Cr -12Cr -153.71Cr -12Cr -12Cr -486.94Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/26/09 | $1.230 | 0.00% | 3,65,600 |
| 08/26/08 | $1.230 | +19.42% | 5,74,177 |
| 04/26/04 | $1.030 | -1.90% | 54,229 |
| 03/26/03 | $1.050 | +5.00% | 78,757 |
| 02/26/02 | $1.000 | +0.45% | 77,574 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATNM Stock
Select your edition
All financial news and data tailored to specific country editions
